CN102325519B - 处理老化皮肤迹象的可食用组合物 - Google Patents
处理老化皮肤迹象的可食用组合物 Download PDFInfo
- Publication number
- CN102325519B CN102325519B CN201080008526.4A CN201080008526A CN102325519B CN 102325519 B CN102325519 B CN 102325519B CN 201080008526 A CN201080008526 A CN 201080008526A CN 102325519 B CN102325519 B CN 102325519B
- Authority
- CN
- China
- Prior art keywords
- edible compositions
- anthocyanidin
- skin
- phylloxanthin
- day
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 71
- 230000032683 aging Effects 0.000 title abstract 2
- 229930014669 anthocyanidin Natural products 0.000 claims abstract description 30
- 235000008758 anthocyanidins Nutrition 0.000 claims abstract description 30
- 150000001452 anthocyanidin derivatives Chemical class 0.000 claims abstract description 29
- 230000037303 wrinkles Effects 0.000 claims abstract description 15
- 108010035532 Collagen Proteins 0.000 claims abstract description 14
- 102000008186 Collagen Human genes 0.000 claims abstract description 14
- 238000000034 method Methods 0.000 claims abstract description 14
- 230000008021 deposition Effects 0.000 claims abstract description 9
- 239000000284 extract Substances 0.000 claims abstract description 8
- 239000002537 cosmetic Substances 0.000 claims abstract description 7
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims abstract description 6
- 229910052802 copper Inorganic materials 0.000 claims abstract description 6
- 239000010949 copper Substances 0.000 claims abstract description 6
- OCUCCJIRFHNWBP-IYEMJOQQSA-L Copper gluconate Chemical compound [Cu+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O OCUCCJIRFHNWBP-IYEMJOQQSA-L 0.000 claims abstract description 3
- QPLDLSVMHZLSFG-UHFFFAOYSA-N Copper oxide Chemical compound [Cu]=O QPLDLSVMHZLSFG-UHFFFAOYSA-N 0.000 claims abstract description 3
- 239000005751 Copper oxide Substances 0.000 claims abstract description 3
- 229940108925 copper gluconate Drugs 0.000 claims abstract description 3
- 229910000431 copper oxide Inorganic materials 0.000 claims abstract description 3
- VEVZSMAEJFVWIL-UHFFFAOYSA-O cyanidin cation Chemical compound [O+]=1C2=CC(O)=CC(O)=C2C=C(O)C=1C1=CC=C(O)C(O)=C1 VEVZSMAEJFVWIL-UHFFFAOYSA-O 0.000 claims description 26
- 235000007336 cyanidin Nutrition 0.000 claims description 13
- 230000003203 everyday effect Effects 0.000 claims description 12
- 241001597008 Nomeidae Species 0.000 claims description 9
- 230000037394 skin elasticity Effects 0.000 claims description 8
- 239000000839 emulsion Substances 0.000 claims description 6
- 150000002148 esters Chemical class 0.000 claims description 6
- 239000007787 solid Substances 0.000 claims description 4
- 229930182478 glucoside Natural products 0.000 claims description 2
- 150000008131 glucosides Chemical class 0.000 claims description 2
- 235000013336 milk Nutrition 0.000 claims description 2
- 239000008267 milk Substances 0.000 claims description 2
- 210000004080 milk Anatomy 0.000 claims description 2
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 abstract description 4
- 229920001436 collagen Polymers 0.000 abstract description 3
- 229960005375 lutein Drugs 0.000 abstract 2
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 abstract 2
- 235000012680 lutein Nutrition 0.000 abstract 2
- 239000001656 lutein Substances 0.000 abstract 2
- 238000007665 sagging Methods 0.000 abstract 2
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 abstract 2
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 abstract 2
- 240000007695 Nandina domestica Species 0.000 abstract 1
- 206010040799 Skin atrophy Diseases 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 230000007717 exclusion Effects 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 25
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 239000003963 antioxidant agent Substances 0.000 description 9
- 235000006708 antioxidants Nutrition 0.000 description 9
- 239000002775 capsule Substances 0.000 description 9
- 230000003078 antioxidant effect Effects 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 8
- 235000013399 edible fruits Nutrition 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 239000003995 emulsifying agent Substances 0.000 description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- 102000012422 Collagen Type I Human genes 0.000 description 5
- 108010022452 Collagen Type I Proteins 0.000 description 5
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 5
- 108010050808 Procollagen Proteins 0.000 description 5
- 239000000796 flavoring agent Substances 0.000 description 5
- 235000013355 food flavoring agent Nutrition 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical group CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 4
- 235000019485 Safflower oil Nutrition 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 235000013361 beverage Nutrition 0.000 description 4
- 239000000787 lecithin Substances 0.000 description 4
- 229940067606 lecithin Drugs 0.000 description 4
- 235000010445 lecithin Nutrition 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 235000019198 oils Nutrition 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 235000005713 safflower oil Nutrition 0.000 description 4
- 239000003813 safflower oil Substances 0.000 description 4
- -1 anthocyanidin Compound Chemical class 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000003366 colagenolytic effect Effects 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N dimethyl sulfoxide Natural products CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000008014 freezing Effects 0.000 description 3
- 238000007710 freezing Methods 0.000 description 3
- 239000006166 lysate Substances 0.000 description 3
- 150000003904 phospholipids Chemical class 0.000 description 3
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 230000000699 topical effect Effects 0.000 description 3
- VOUAQYXWVJDEQY-QENPJCQMSA-N 33017-11-7 Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N1[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O)CCC1 VOUAQYXWVJDEQY-QENPJCQMSA-N 0.000 description 2
- 108010075254 C-Peptide Proteins 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 2
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 2
- ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 description 2
- 235000011552 Rhamnus crocea Nutrition 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- BGNXCDMCOKJUMV-UHFFFAOYSA-N Tert-Butylhydroquinone Chemical compound CC(C)(C)C1=CC(O)=CC=C1O BGNXCDMCOKJUMV-UHFFFAOYSA-N 0.000 description 2
- 244000078534 Vaccinium myrtillus Species 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 235000003650 acai Nutrition 0.000 description 2
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- 239000011111 cardboard Substances 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- ZQSIJRDFPHDXIC-UHFFFAOYSA-N daidzein Chemical compound C1=CC(O)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZQSIJRDFPHDXIC-UHFFFAOYSA-N 0.000 description 2
- 235000015872 dietary supplement Nutrition 0.000 description 2
- DVSZKTAMJJTWFG-UHFFFAOYSA-N docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCCC=CC=CC=CC=CC=CC=CC(O)=O DVSZKTAMJJTWFG-UHFFFAOYSA-N 0.000 description 2
- MBMBGCFOFBJSGT-KUBAVDMBSA-N docosahexaenoic acid Natural products CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 2
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 2
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 2
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 2
- 210000002744 extracellular matrix Anatomy 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000004250 tert-Butylhydroquinone Substances 0.000 description 2
- 235000019281 tert-butylhydroquinone Nutrition 0.000 description 2
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- GJJVAFUKOBZPCB-UHFFFAOYSA-N 2-methyl-2-(4,8,12-trimethyltrideca-3,7,11-trienyl)-3,4-dihydrochromen-6-ol Chemical compound OC1=CC=C2OC(CCC=C(C)CCC=C(C)CCC=C(C)C)(C)CCC2=C1 GJJVAFUKOBZPCB-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- KQIKOUUKQBTQBE-UHFFFAOYSA-N 3,5,7-trihydroxy-2-(4-hydroxy-3,5-dimethoxyphenyl)-1lambda^{4}-chromen-1-ylium chloride Chemical compound [Cl-].COC1=C(O)C(OC)=CC(C=2C(=CC=3C(O)=CC(O)=CC=3[O+]=2)O)=C1 KQIKOUUKQBTQBE-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- 241000093727 Berzelia alopecuroides Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- RKWHWFONKJEUEF-GQUPQBGVSA-O Cyanidin 3-O-glucoside Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC2=C(O)C=C(O)C=C2[O+]=C1C1=CC=C(O)C(O)=C1 RKWHWFONKJEUEF-GQUPQBGVSA-O 0.000 description 1
- RDFLLVCQYHQOBU-GPGGJFNDSA-O Cyanin Natural products O([C@H]1[C@H](O)[C@H](O)[C@H](O)[C@H](CO)O1)c1c(-c2cc(O)c(O)cc2)[o+]c2c(c(O[C@H]3[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O3)cc(O)c2)c1 RDFLLVCQYHQOBU-GPGGJFNDSA-O 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- GCPYCNBGGPHOBD-UHFFFAOYSA-N Delphinidin Natural products OC1=Cc2c(O)cc(O)cc2OC1=C3C=C(O)C(=O)C(=C3)O GCPYCNBGGPHOBD-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 244000207620 Euterpe oleracea Species 0.000 description 1
- 235000012601 Euterpe oleracea Nutrition 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- RKWHWFONKJEUEF-WVXKDWSHSA-O Idaein Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CC2=C(O)C=C(O)C=C2[O+]=C1C1=CC=C(O)C(O)=C1 RKWHWFONKJEUEF-WVXKDWSHSA-O 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 229940123973 Oxygen scavenger Drugs 0.000 description 1
- 240000007651 Rubus glaucus Species 0.000 description 1
- 235000011034 Rubus glaucus Nutrition 0.000 description 1
- 235000009122 Rubus idaeus Nutrition 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 235000006468 Thea sinensis Nutrition 0.000 description 1
- 102000004887 Transforming Growth Factor beta Human genes 0.000 description 1
- 108090001012 Transforming Growth Factor beta Proteins 0.000 description 1
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 1
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 1
- 241000759263 Ventia crocea Species 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000011805 ball Substances 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- 235000020279 black tea Nutrition 0.000 description 1
- 235000021014 blueberries Nutrition 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 235000021152 breakfast Nutrition 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 229910002091 carbon monoxide Inorganic materials 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- YTMNONATNXDQJF-UBNZBFALSA-N chrysanthemin Chemical compound [Cl-].O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC2=C(O)C=C(O)C=C2[O+]=C1C1=CC=C(O)C(O)=C1 YTMNONATNXDQJF-UBNZBFALSA-N 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000002079 cooperative effect Effects 0.000 description 1
- 239000002178 crystalline material Substances 0.000 description 1
- YTMNONATNXDQJF-QSLGVYCOSA-N cyanidin 3-O-beta-D-galactoside chloride Chemical compound [Cl-].O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CC2=C(O)C=C(O)C=C2[O+]=C1C1=CC=C(O)C(O)=C1 YTMNONATNXDQJF-QSLGVYCOSA-N 0.000 description 1
- USNPULRDBDVJAO-FXCAAIILSA-O cyanidin 3-O-rutinoside Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(=[O+]C3=CC(O)=CC(O)=C3C=2)C=2C=C(O)C(O)=CC=2)O1 USNPULRDBDVJAO-FXCAAIILSA-O 0.000 description 1
- RDFLLVCQYHQOBU-ZOTFFYTFSA-O cyanin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=[O+]C1=CC(O)=C2)C=3C=C(O)C(O)=CC=3)=CC1=C2O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 RDFLLVCQYHQOBU-ZOTFFYTFSA-O 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 235000007240 daidzein Nutrition 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- JKHRCGUTYDNCLE-UHFFFAOYSA-O delphinidin Chemical compound [O+]=1C2=CC(O)=CC(O)=C2C=C(O)C=1C1=CC(O)=C(O)C(O)=C1 JKHRCGUTYDNCLE-UHFFFAOYSA-O 0.000 description 1
- 235000007242 delphinidin Nutrition 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 239000012470 diluted sample Substances 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 235000012055 fruits and vegetables Nutrition 0.000 description 1
- 229940098330 gamma linoleic acid Drugs 0.000 description 1
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 description 1
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 235000006539 genistein Nutrition 0.000 description 1
- 229940045109 genistein Drugs 0.000 description 1
- TZBJGXHYKVUXJN-UHFFFAOYSA-N genistein Natural products C1=CC(O)=CC=C1C1=COC2=CC(O)=CC(O)=C2C1=O TZBJGXHYKVUXJN-UHFFFAOYSA-N 0.000 description 1
- ZCOLJUOHXJRHDI-CMWLGVBASA-N genistein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 ZCOLJUOHXJRHDI-CMWLGVBASA-N 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 235000020688 green tea extract Nutrition 0.000 description 1
- 229940094952 green tea extract Drugs 0.000 description 1
- LHGVFZTZFXWLCP-UHFFFAOYSA-N guaiacol Chemical class COC1=CC=CC=C1O LHGVFZTZFXWLCP-UHFFFAOYSA-N 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 229960001331 keracyanin Drugs 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- LRDGATPGVJTWLJ-UHFFFAOYSA-N luteolin Natural products OC1=CC(O)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 LRDGATPGVJTWLJ-UHFFFAOYSA-N 0.000 description 1
- IQPNAANSBPBGFQ-UHFFFAOYSA-N luteolin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C(O)=C1 IQPNAANSBPBGFQ-UHFFFAOYSA-N 0.000 description 1
- 235000009498 luteolin Nutrition 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 239000003264 margarine Substances 0.000 description 1
- 235000013310 margarine Nutrition 0.000 description 1
- 239000008268 mayonnaise Substances 0.000 description 1
- 235000010746 mayonnaise Nutrition 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- JCXJVPUVTGWSNB-UHFFFAOYSA-N nitrogen dioxide Inorganic materials O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 229960002969 oleic acid Drugs 0.000 description 1
- 238000010525 oxidative degradation reaction Methods 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 239000011087 paperboard Substances 0.000 description 1
- XVFMGWDSJLBXDZ-UHFFFAOYSA-O pelargonidin Chemical compound C1=CC(O)=CC=C1C(C(=C1)O)=[O+]C2=C1C(O)=CC(O)=C2 XVFMGWDSJLBXDZ-UHFFFAOYSA-O 0.000 description 1
- HKUHOPQRJKPJCJ-UHFFFAOYSA-N pelargonidin Natural products OC1=Cc2c(O)cc(O)cc2OC1c1ccc(O)cc1 HKUHOPQRJKPJCJ-UHFFFAOYSA-N 0.000 description 1
- 235000006251 pelargonidin Nutrition 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 235000010388 propyl gallate Nutrition 0.000 description 1
- 239000000473 propyl gallate Substances 0.000 description 1
- 229940075579 propyl gallate Drugs 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 238000012207 quantitative assay Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000000611 regression analysis Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 235000015067 sauces Nutrition 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 210000001626 skin fibroblast Anatomy 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 238000009331 sowing Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000009955 starching Methods 0.000 description 1
- 239000012089 stop solution Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229930003802 tocotrienol Natural products 0.000 description 1
- 239000011731 tocotrienol Substances 0.000 description 1
- 235000019148 tocotrienols Nutrition 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/92—Oral administration
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Botany (AREA)
- Dermatology (AREA)
- Biotechnology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Microbiology (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Emergency Medicine (AREA)
- Cosmetics (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及一种处理老化皮肤迹象的可食用组合物，特别是与丧失皮肤弹性、皱纹和松弛有关的那些皮肤迹象。因此，本发明组合物提供了选自以下的皮肤益处：提高胶原蛋白在皮肤中的沉积、减少皱纹的出现和减少松弛。因此本发明提供了一种处理老化皮肤的可食用的组合物，所述组合物包含：（a）2-1000，优选5-750，最优选10-500毫克的花色素及其衍生物；和（b）1-20，优选5-15，最优选2-10毫克叶黄素及其衍生物；其中所述花色素与叶黄素的重量比为至少1:1，优选至少10:1，更优选至少25:1，更加优选至少50:1，最优选至少100:1；其中所述组合物排除独立形式或与葡萄糖酸铜和氧化铜相结合形式的铜；并且还独立排除或与上述铜排除一起排除南天竹或其提取物。本发明也涉及使用本发明组合物提供所述皮肤益处的化妆方法。
Description
本发明涉及提供一种处理老化皮肤迹象的可食用组合物，特别是与丧失皮肤弹性、皱纹和松弛有关的那些皮肤迹象。因此，本发明组合物提供了选自以下的皮肤益处：提高胶原蛋白在皮肤中的沉积、减少皱纹的出现和减少松弛。本发明也涉及一种用于提供所述皮肤益处的化妆方法。
发明内容
在本发明的第一方面，提供了一种处理老化皮肤的可食用组合物，所述组合物包含：
（a）2-1000，优选5-750，最优选10-500毫克的花色素及其衍生物；和
（b）1-20，优选2-15，更优选2-10，最优选3-10毫克的叶黄素及其衍生物；
其中所述花色素与叶黄素的重量比为至少1:1，优选至少10:1，更优选至少25:1，更加优选至少50:1，最优选至少100:1；
其中所述组合物排除独立形式或与葡萄糖酸铜和氧化铜相结合形式的铜；
并且还独立排除或与所述铜排除一起排除南天竹或其提取物。
本发明的基础源自于发明人发现：花色素和叶黄素协同作用，以提供提高水平的I型溶胶原，其是I型胶原蛋白的前体。因为I型溶胶原的数量化学计量地反映合成的I型胶原蛋白的数量，因此I型溶胶原的合成被认为是I型胶原蛋白合成的标志。I型胶原蛋白是最丰富的胶原蛋白类型，并且其尤其在皮肤中发现。胶原蛋白的束称为胶原蛋白纤维，其是细胞外基质的主要组分，所述细胞外基质支撑大多数组织并从外部赋予细胞结构。特别地，I型胶原蛋白是皮肤的主要组分，其负责赋予皮肤以强度和弹性。因此，它随年龄的降解导致皱纹和松弛。因此，使用本发明组合物将改善皮肤弹性并减少皱纹和松弛的出现。
术语“其衍生物”在涉及花色素时，意在包括相关花青素衍生物，其实例是葡糖苷，芦丁糖苷和槐糖苷。
术语“可食用的”指的是人可食用的。所述组合物可以是乳液形式，其结合或未结合乳固体。
所述花色素可以选自橙曲菌素（aurantindin），矢车菊色素，花燕草色素，europindin，藤黄菌素（luteolindin），天竺葵色素，锦葵色素，芍药色素，3'-甲花翠素和rosindin。优选所述花色素是矢车菊色素。任选的是，所述花色素的衍化物是花青素。
一般，矢车菊色素本身独立存在或者与一种或多种其它花色素类化合物相结合存在。经常，在存在矢车菊色素时，化合物矢车菊色素苷，越桔色苷，花青素鼠李葡萄糖苷，花青-3-葡糖苷及其衍生物仅以痕量存在，如同天然植物提取物常见的那样。例如，所涉及化合物可以占本发明组合物的矢车菊色素组分的重量的小于1wt%，优选小于0.2wt%，经常小于0.05wt%，更经常小于0.01wt%。优选的是矢车菊色素与其它花色素化合物相结合存在，所述矢车菊色素的存在量为花色素组分的超过50重量%，优选超过75重量%。
包括矢车菊色素的花色素是在许多红色浆果中发现的色素，所述红色浆果包括但不限于覆盆子，黑莓，蓝莓，樱桃，红莓，接骨木果，山楂，罗甘莓，巴西莓（acai berry）和树莓。它们也在其它水果如苹果和李子中发现。在所述水果的皮中发现最高浓度的花色素。
所述叶黄素的衍化物可以是其酯。
所述组合物优选包括一种或多种额外组分，其选自抗氧化剂，调味剂，防腐剂和稳定剂。
本发明的组合物可以呈现任何适合形式，包括例如食品和营养增补剂。口服的组合物包括饮料，条及其它液体和固体形式，如片、丸、胶囊和粉末（其可以含结晶材料）以及涂抹料，人造黄油，膏剂，沙司，装饰料，蛋黄酱，冰淇淋，馅料，糖果和麦片。本发明组合物可以以带有局部组合物的试剂盒的形式出售，所述局部组合物具有选自提高胶原蛋白在皮肤中沉积，减少皱纹的出现和减少松弛的相同皮肤护理益处。因此，这种试剂盒包括本发明的处理老化皮肤的可食用组合物和在上文提到的局部组合物，在使用时，其可以从皮肤“内侧”和“外侧”都起作用，以提供选自提高胶原蛋白在皮肤中的沉积、减少皱纹的出现和减少松弛的所述皮肤护理益处。
在一个实施方案中，本发明组合物优选是水基的，即包含至少50%水，优选至少60%或至少70%w/w水。其可以是液体或冷冻的。因此所述产品具有常规水基产品的感觉，并可以定期消费，作为消费者的日常饮食的一部分。例如，它可以取代通常在早餐时间消费的果汁。本发明组合物优选包装成饮料，例如包装在容器如硬纸盒或上浆纸或纸板、玻璃或塑料制成的瓶中。所述容器优选容积为10-500毫升，如20-100毫升。
在一个备选实施方案中，本发明组合物装在胶囊中，与告知用户建议的服用方法的说明书一起提供。所述胶囊可以由本领域公知的任何适合材料（如明胶）构成。所述胶囊适用于由消费者吞咽，通常每天一到四次服用一个或二个胶囊。
或者，本发明组合物可以包括成复合食品的一个组分，例如所述组合物可以以固体或胶状的形式存在，作为条或类似产品内的馅料或层。所述组合物因此可以被引入各种日常食品，例如在“保健食品”条中，其可以作为其它小吃食品的替代而食用。
除了花色素及其衍生物（它们本身就是抗氧化剂）以外的一种或多种额外抗氧化剂优选存在于本发明组合物中，以防止或减缓所述组合物的天然氧化降解。适合的额外抗氧化剂可以选自但不是排他性地选自以下所列的物质，它们可以独立存在或彼此结合：叔丁基对苯二酚（TBHQ），抗坏血酸酯（例如抗坏血酰棕榈酸酯），抗坏血酸，生育酚，迷迭香提取物，水果浓缩物或提取物，红茶或绿茶提取物，没食子酸丙酯，丁基化羟基苯甲醚（BHA），丁基化羟基甲苯（BHT），柠檬酸或酯，生育三烯酚，多酚，酚化合物，其它类黄酮化合物和氧清除剂。尤其优选的额外抗氧化剂是维生素C和E。这些不仅是有效的抗氧化剂，而且在消费时它们还显示出赋予皮肤益处。额外抗氧化剂的数量可以是在典型的至少6个月的保质期内足以防止所述组合物发生腐败的量。显然，抗氧化剂的数量将取决于所用抗氧化剂的类型和活性。
本发明组合物可以包含调味剂，但是如果通过调味物质如果蔬汁提供所述叶黄素或花色素时，就没必要加入调味剂。适合的调味剂可以是天然的或合成的。可能需要调味剂以使得所述产品消费起来更适口。
所述组合物可以包含乳化剂，更优选食品级磷脂乳化剂。优选所述磷脂乳化剂是卵磷脂。磷脂乳化剂是油溶性的，但是所述卵磷脂可以在乳化前加入任一相中。优选将它加到水相中。任何乳化剂优选在所述组合物中的存在量为至少0.01%，优选0.05-3%，更优选0.1-1%w/w。
本发明组合物可以包含多不饱和脂肪酸，如ω-3脂肪酸（即具有12-26个碳原子的不饱和羧酸）。优选的ω-3脂肪酸选自二十二碳六烯酸（DHA），二十碳五烯酸（EPA）和其混合物。适合的多不饱和脂肪酸也可以选自油酸，亚油酸，γ-亚油酸，亚麻酸，花生四烯酸。所述多不饱和脂肪酸可以作为天然油（如鱼油）的组分存在。
所述组合物也可以包含大豆异黄酮（包含染料木黄酮或黄豆苷原，其呈糖基化的和/或非糖基化的形式），一般的量为0.0001-0.1%w/w。
本发明组合物可以通过制备水相和油相来制备。如果使用乳化剂，优选将其加入水相。然后共混所述油相和水相以形成乳液。在一种优选方法中，所述油在粉末载体材料上以帮助形成乳液。然后可将乳液包装在密封容器，如金属、涂敷纸板（例如Tetra Pak）或塑料容器中。然后优选将所述容器密封而不留下顶部空间或留下排除氧的气体填充（例如氮或二氧化碳）的顶部空间。这进一步有助于防止氧化。或者，所述乳液可以冷冻和包装并以冷冻消费品进行销售。
在本发明的第二方面，提供了一种用于提供选自以下的皮肤益处的化妆方法：提高胶原蛋白在皮肤中的沉积，改善皮肤弹性，减少皱纹的出现和减少松弛，所述方法包括每日给予本发明组合物，每天至少一份，优选至少两份，更优选至少三份，最优选至少四份相同或不同的份额。
在本发明的第三方面，提供了本发明的可食用组合物的用途，用于提供选自以下的皮肤益处：提高胶原蛋白在皮肤中的沉积，改善皮肤弹性，减少皱纹的出现和减少松弛。
在本发明的第四方面，提供了本发明的可食用组合物的用途，用于提供选自以下的皮肤益处：提高胶原蛋白在皮肤中的沉积，改善皮肤弹性，减少皱纹的出现和减少松弛，所述用途包括给予本发明组合物，每天至少一份，优选至少两份，更优选至少三份，最优选至少四份相同或不同的份额(serving)。
附图说明
现在在下文中将参考以下附图对本发明进行举例说明：
图1显示对于包含各μM浓度的叶黄素、矢车菊色素或两者的试验溶液，每μg蛋白质中的I型溶胶原的ng浓度。
具体实施方式
实施例1：叶黄素和矢车菊色素对原发人皮肤成纤维细胞中的I型溶胶原水平的影响
将第一组原发人皮肤的成纤维细胞在Dulbecco改良的Eagle培养基（Dulbecco's modified Eagle medium，DMEM）中培养，所述培养基购自Gibco，并补加10%胎牛血清（FBS）。然后将所述细胞在6-孔组织培养皿中，以在每个孔的2毫升完全培养基（DMEM和FBS的混合物）中播种密度为约5000个细胞/平方厘米，按常规铺板24小时，并在37oC在5%CO2中培养。然后除去所述完全培养基，并在处理前使所述细胞在DMEM和1%FBS中生长24小时。然后对所述细胞进行计数，制粒并对细胞溶胞产物进行针对I型溶胶原-1（PC-1）表达的分析。
制备用于针对I型溶胶原-1（PC-1）表达的分析的第二组细胞，其与上述第一组细胞的不同之处在于，它们用1mM的4-β-佛波醇-12-肉豆蔻酸酯-13-乙酸酯（PMA）（Sigma P8139）进行氧化应激24小时，以使得PMA的最终浓度为1μM。然后，通过分析细胞上清液的乳酸脱氢酶（其因细胞死亡而释放），测定细胞毒性水平。PMA模拟了紫外辐射对皮肤细胞的影响，并降低胶原蛋白合成。然后对所述细胞进行计数，制粒并对细胞溶胞产物进行针对I型溶胶原-1（PC-1）表达的分析。
试验溶液制备在DMEM中，其包含1%FBS和各种μM浓度的叶黄素，矢车菊色素或两者，如图1所示。
购自Takara Bio Incorporated的I型溶胶原C-肽酶免疫分析（EIA）试剂盒使得可以对I型溶胶原C-肽（P1 P）进行定量测定。制备八个P1 P标准品，样品稀释物浓度范围为0-640纳克/毫升。将100微升的抗体-过氧化物酶共轭溶液与20微升细胞溶胞产物（1微克蛋白质）或一个标准品加入两个孔中。将所述孔板密封并在37oC培养3小时，然后用400微升磷酸盐缓冲液（PBS）洗涤四次。然后将各孔中盛上100微升所述试剂盒中提供的底物溶液，并将孔板在室温下培养15分钟。此后，向各孔中加入100微升停止溶液，其也由所述试剂盒提供，并用孔板读取器在450nm测量吸光度。将相对于P1 P浓度的平均吸光度制成标准曲线，并通过回归分析计算最佳拟合的线。由此估算所有试验溶液的未知P1 P浓度。结果显示在图1中，其清楚表明叶黄素和矢车菊色素的结合对升高I型溶胶原水平的协同效应。转化生长因子β（TGF β）用作阳性对照物。介质是二甲基亚砜（DMSO）。
实施例2：包含接骨木果衍生的花青素和叶黄素的胶囊
胶囊包封法是本领域技术人员公知的，一般包括合并125毫克标准化的25%花青素接骨木果提取物（Artemis International Inc.），12.5毫克叶黄素在红花油中的20%悬浮液（购自Kemin Health LC的在红花油中的20%FloraGlo lutein液体），8毫克硬脂酸镁和12毫克二氧化硅，并将混合物包封在羟丙基甲基纤维素（HPMC）胶囊中。
早上服用两粒胶囊，晚上再服用另外两粒胶囊。一般在12周之后可观察到改善皮肤弹性、减少皱纹的出现和减少松弛的可见迹象。
实施例3
合并100毫克卵磷脂，100微升叶黄素在红花油中的20%悬浮液（购自Kemin Health LC的在红花油中的20%FloraGlo lutein液体），4克标准化的25%花青素接骨木果提取物（Artemis International Inc.）和水以补足到100毫升，由此产生一种饮料。
通过首先在常规乳化装置中将卵磷脂共混到水中，然后共混叶黄素和接骨木果提取物，从而制成所述饮料。
Claims (21)
1.一种处理老化皮肤的可食用的组合物，其包含：
（a）2-1000毫克的花色素及其衍生物，其中所述花色素是矢车菊色素，花色素的衍化物选自葡糖苷，芦丁糖苷和槐糖苷；和
（b）1-20毫克的叶黄素及其酯；
其中所述花色素与叶黄素的重量比为至少1:1；
其中所述组合物排除独立形式或与葡萄糖酸铜和氧化铜相结合形式的铜；
并且还独立排除或与上述铜排除一起排除南天竹或其提取物。
2.根据权利要求1的可食用的组合物，其包含5-750毫克的花色素及其衍生物。
3.根据权利要求1的可食用的组合物，其包含10-500毫克的花色素及其衍生物。
4.根据权利要求1的可食用的组合物，其包含2-15毫克的叶黄素及其酯。
5.根据权利要求1的可食用的组合物，其包含2-10毫克的叶黄素及其酯。
6.根据权利要求1的可食用的组合物，其包含3-10毫克的叶黄素及其酯。
7.根据权利要求1的可食用的组合物，其中所述花色素与叶黄素的重量比为至少10:1。
8.根据权利要求1的可食用的组合物，其中所述花色素与叶黄素的重量比为至少25:1。
9.根据权利要求1的可食用的组合物，其中所述花色素与叶黄素的重量比为50:1。
10.根据权利要求1的可食用的组合物，其中所述花色素与叶黄素的重量比为至少100:1。
11.根据权利要求1的可食用的组合物，其为乳液形式。
12.根据权利要求1的可食用的组合物，其还包含乳固体。
13.一种用于提供选自以下的皮肤益处的化妆方法：提高胶原蛋白在皮肤中的沉积，改善皮肤弹性，减少皱纹的出现和减少松弛，所述方法包括给予根据权利要求1-12任一项的可食用的组合物，每天至少一份相同或不同的份额。
14.根据权利要求13的化妆方法，所述方法包括给予根据权利要求1-12任一项的可食用的组合物，每天至少两份相同或不同的份额。
15.根据权利要求13的化妆方法，所述方法包括给予根据权利要求1-12任一项的可食用的组合物，每天至少三份相同或不同的份额。
16.根据权利要求13的化妆方法，所述方法包括给予根据权利要求1-12任一项的可食用的组合物，每天至少四份相同或不同的份额。
17.根据权利要求1-12任一项的可食用的组合物的用途，用于提供选自以下的皮肤益处：提高胶原蛋白在皮肤中的沉积，改善皮肤弹性，减少皱纹的出现和减少松弛。
18.根据权利要求1-12任一项的可食用的组合物的用途，用于提供选自以下的皮肤益处：提高胶原蛋白在皮肤中的沉积，减少皱纹的出现和减少松弛，所述用途包括给予所述可食用的组合物，每天至少一份相同或不同的份额。
19.根据权利要求18的用途，所述用途包括给予所述可食用的组合物，每天至少两份相同或不同的份额。
20.根据权利要求18的用途，所述用途包括给予所述可食用的组合物，每天至少三份相同或不同的份额。
21.根据权利要求18的用途，所述用途包括给予所述可食用的组合物，每天至少四份相同或不同的份额。
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09153407.3 | 2009-02-23 | ||
| EP09153407 | 2009-02-23 | ||
| PCT/EP2010/051933 WO2010094687A1 (en) | 2009-02-23 | 2010-02-16 | Edible composition for treating cutaneous signs of ageing |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102325519A CN102325519A (zh) | 2012-01-18 |
| CN102325519B true CN102325519B (zh) | 2014-10-29 |
Family
ID=40963429
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201080008526.4A Active CN102325519B (zh) | 2009-02-23 | 2010-02-16 | 处理老化皮肤迹象的可食用组合物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US8158164B2 (zh) |
| EP (1) | EP2398449B1 (zh) |
| CN (1) | CN102325519B (zh) |
| BR (1) | BRPI1008607B1 (zh) |
| CA (1) | CA2751511C (zh) |
| MX (1) | MX2011008877A (zh) |
| WO (1) | WO2010094687A1 (zh) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105213367A (zh) * | 2015-10-28 | 2016-01-06 | 邓宏伟 | 越橘花青素组合物及其在制备防治近视药物或食品的应用 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6200601B1 (en) * | 1998-09-04 | 2001-03-13 | Amway Corporation | Softgel capsule containing Dha and antioxidants |
| US20030108624A1 (en) * | 1997-02-04 | 2003-06-12 | Kosbab John V. | Compositions and methods for prevention and treatment of chronic diseases and disorders including the complications of diabetes mellitus |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6248611A (ja) | 1985-08-28 | 1987-03-03 | Shiseido Co Ltd | 皮膚外用剤 |
| US6086910A (en) | 1997-09-19 | 2000-07-11 | The Howard Foundation | Food supplements |
| US6194469B1 (en) | 1998-12-11 | 2001-02-27 | Board Of Trustees Operating Michigan State Univeristy | Method for inhibiting cyclooxygenase and inflammation using cherry bioflavonoids |
| JP3156928B1 (ja) | 1999-12-21 | 2001-04-16 | カネボウ株式会社 | 皮膚ひきしめ剤および化粧料 |
| US20020037855A1 (en) | 2000-05-05 | 2002-03-28 | Fritz Stanislaus | Stabilized medicament containing cysteinyl derivatives |
| US7030092B1 (en) | 2001-08-24 | 2006-04-18 | Small Giant L.L.C. | Ultra-high fiber supplement and method of reducing weight cardiovascular risks and ingested toxins. |
| US20030105027A1 (en) | 2001-11-06 | 2003-06-05 | Rosenbloom Richard A. | Nutritional supplements and methods for prevention, reduction and treatment of radiation injury |
| JP4397142B2 (ja) | 2001-11-20 | 2010-01-13 | 株式会社林原生物化学研究所 | 活性酸素消去能低減抑制剤 |
| WO2003063860A1 (fr) | 2002-01-31 | 2003-08-07 | Kansai Technology Licensing Organization Co., Ltd. | Composition et procede pour la prevention du cancer chez des sujets humains |
| WO2004014413A1 (en) | 2002-07-31 | 2004-02-19 | Procyte Corporation | Compositions containing peptide copper complexes and phytochemical compounds, and methods related thereto |
| JP2004107245A (ja) | 2002-09-17 | 2004-04-08 | Fancl Corp | 目元のくすみ・クマ・むくみ改善用キット |
| US20040109905A1 (en) | 2002-09-18 | 2004-06-10 | Debasis Bagchi | Method and composition of anthocyanin-rich berry extracts that prevents or inhibits angiogenesis and helicobacter pylori and acts as a powerful antioxidant that provides various health benefits |
| US9192586B2 (en) | 2003-03-10 | 2015-11-24 | Zeavision Llc | Zeaxanthin formulations with additional ocular-active nutrients, for protecting eye health and treating eye disorders |
| US20040146539A1 (en) | 2003-01-24 | 2004-07-29 | Gupta Shyam K. | Topical Nutraceutical Compositions with Selective Body Slimming and Tone Firming Antiaging Benefits |
| US7179477B2 (en) | 2003-08-15 | 2007-02-20 | Shyam K Gupta | Cosmetic dermabrasion treatment system |
| US7320797B2 (en) | 2003-08-29 | 2008-01-22 | Bioderm Research | Antiaging cosmetic delivery systems |
| JP2006070016A (ja) | 2004-08-02 | 2006-03-16 | Kaneka Corp | 還元型補酵素ｑを含有する美白用組成物 |
| US20060089411A1 (en) | 2004-08-07 | 2006-04-27 | Gierhart Dennis L | Treatment of Stargardt's disease and other lipofuscin disorders with combined retinaldehyde inhibitor and zeaxanthin |
| US7666442B2 (en) | 2004-08-31 | 2010-02-23 | Tracie Martyn International, Llc | Topical compositions comprising benfotiamine and pyridoxamine |
| CN101188948A (zh) | 2005-04-04 | 2008-05-28 | 阿彻-丹尼尔斯-米德兰公司 | 包含木酚素的组合物 |
| US8703228B2 (en) | 2005-05-23 | 2014-04-22 | Intercontinental Great Brands Llc | Confectionery composition including an elastomeric component, a cooked saccharide component, and a modified release component |
| US20060280762A1 (en) | 2005-05-31 | 2006-12-14 | Richard Kostick | Color Cosmetics - Coloring/Staining the skin from fruit and plant color pigments |
| JP2007308396A (ja) | 2006-05-16 | 2007-11-29 | Tokiwa Yakuhin Kogyo Kk | 眼精疲労用組成物 |
| MX2008015299A (es) | 2006-06-01 | 2009-02-06 | Sakura Properties Llc | Composiciones de fucoidano y métodos. |
| JP5459939B2 (ja) | 2006-06-09 | 2014-04-02 | 富士フイルム株式会社 | カロチノイド含有エマルジョン組成物、その製造方法、それを含む食品及び化粧品 |
| US20080207774A1 (en) | 2006-08-24 | 2008-08-28 | Venkataram Krishnan | Anionic latex as a carrier for active ingredients and methods for making and using the same |
| US7282225B1 (en) | 2006-09-27 | 2007-10-16 | Occular Technologies, Inc. | Composition and methods for improving retinal health |
| CN1957903A (zh) | 2006-10-17 | 2007-05-09 | 颜怀伟 | 胶原蛋白复合氨基酸复合中药抗皱抗衰可食护肤品及制造方法 |
| CN1957886A (zh) | 2006-10-17 | 2007-05-09 | 颜怀伟 | 抗皱抗衰胶原蛋白复合氨基酸可食性化妆护肤品及制造方法 |
| JP2008110933A (ja) | 2006-10-30 | 2008-05-15 | Four Leaf Japan:Kk | 抗酸化組成物およびこれを含む製品 |
| US20080134492A1 (en) | 2006-12-11 | 2008-06-12 | Uchicago Argonne, Llc | Poly(ethyleneoxide) siloxane gel electrolytes |
-
2010
- 2010-02-16 CA CA2751511A patent/CA2751511C/en not_active Expired - Fee Related
- 2010-02-16 MX MX2011008877A patent/MX2011008877A/es active IP Right Grant
- 2010-02-16 CN CN201080008526.4A patent/CN102325519B/zh active Active
- 2010-02-16 WO PCT/EP2010/051933 patent/WO2010094687A1/en active Application Filing
- 2010-02-16 EP EP10703902.6A patent/EP2398449B1/en active Active
- 2010-02-16 BR BRPI1008607A patent/BRPI1008607B1/pt not_active IP Right Cessation
- 2010-02-18 US US12/707,706 patent/US8158164B2/en active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030108624A1 (en) * | 1997-02-04 | 2003-06-12 | Kosbab John V. | Compositions and methods for prevention and treatment of chronic diseases and disorders including the complications of diabetes mellitus |
| US6200601B1 (en) * | 1998-09-04 | 2001-03-13 | Amway Corporation | Softgel capsule containing Dha and antioxidants |
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI1008607A2 (pt) | 2016-03-15 |
| MX2011008877A (es) | 2011-09-21 |
| US8158164B2 (en) | 2012-04-17 |
| US20100215762A1 (en) | 2010-08-26 |
| BRPI1008607B1 (pt) | 2017-04-18 |
| EP2398449B1 (en) | 2017-09-06 |
| CA2751511C (en) | 2017-04-11 |
| EP2398449A1 (en) | 2011-12-28 |
| WO2010094687A1 (en) | 2010-08-26 |
| CA2751511A1 (en) | 2010-08-26 |
| CN102325519A (zh) | 2012-01-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100374044C (zh) | 含有生物活性亲脂化合物的初级组合物 | |
| Cid-Ortega et al. | Roselle calyces (Hibiscus sabdariffa), an alternative to the food and beverages industries: a review | |
| EP1833498B1 (en) | Oral composition for enhancing skin properties | |
| CN1662229B (zh) | 牛磺酸和/或亚牛磺酸在制备治疗秃头症的药物中的应用 | |
| EP2004160B1 (en) | Oral composition with an antiageing effect on the skin | |
| MX2008013284A (es) | Preparacion de polifenol regaliz. | |
| JP4658290B2 (ja) | 線維芽細胞増殖作用剤、美容用飲食品および皮膚化粧料 | |
| Ghosh et al. | Nature’s palette: An emerging frontier for coloring dairy products | |
| JP2002003393A (ja) | 線維芽細胞増殖作用剤、美容用飲食品および皮膚化粧料 | |
| Choi et al. | Physicochemical properties and antioxidant activity of colored peppers (Capsicum annuum L.) | |
| CN104822424A (zh) | 局部施用类视黄醇化合物后增强皮肤耐受性的口服组合物 | |
| CN102325519B (zh) | 处理老化皮肤迹象的可食用组合物 | |
| RU2305989C1 (ru) | Способ производства консервов "треска тушеная с капустой" специального назначения (варианты) | |
| JP2006045100A (ja) | α−リポ酸含有カプセル剤 | |
| CN102245177B (zh) | 口服组合物 | |
| Ghoshal | Beverages: A potential delivery system for nutraceuticals | |
| Korzeniowska et al. | Advances in food fortification with vitamins and co-vitamins | |
| RU2303882C1 (ru) | Способ производства консервов "печень по-строгановски" специального назначения (варианты) | |
| US20220369660A1 (en) | Glycyrrhiza and the prevention of lc-pufa oxidation | |
| Silva Espinoza | Design of the process of obtaining a freeze-dried orange puree. Formulation, freeze-drying variables, and storage conditions | |
| JP2023166586A (ja) | 網膜保護組成物 | |
| JP2024023667A (ja) | 肝機能改善剤 | |
| Herring et al. | EC05-473 Functional Foods | |
| BR102016004113A2 (pt) | Formulated pharmaconutrients based on anacardium occidentale l. with antioxidant, nutraceutical, immunomodulating and dietary supplementation application |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20210824 Address after: Rotterdam Patentee after: Unilever Intellectual Property Holdings Ltd. Address before: Rotterdam Patentee before: Netherlands Unilever Co.,Ltd. |